Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus + mycophenolate mofetil versus ciclosporine + azathioprine in renal transplantation
ACTRN12610000697088Phase 4Active, not recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Feb 2000
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in kidney allograft rejection and chronic kidney disease (CKD) comparing Tacrolimus + mycophenolate mofetil with Ciclosporine + azathioprine (2 arms). Primary endpoint: Clinical acute rejection during the first year. Started Feb 2000; status: active, not recruiting.
02
Drugs
tacrolimusmycophenolate mofetilciclosporinazathioprine
03
Conditions
kidney allograft rejectionchronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12610000697088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000697088.